Nathan A. Berger

机构：University School, University of Houston, Case Western Reserve University · ORCID：0000-0001-7086-9885

发表论文 360 篇 · 总被引 16708 次 · h-index 68

代表论文

• Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes (2024 · JAMA Network Open · 被引 294)
• Association of semaglutide with risk of suicidal ideation in a real-world cohort (2024 · Nature Medicine · 被引 243)
• GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity (2023 · JAMA Oncology · 被引 149)
• Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population (2024 · Nature Communications · 被引 135)
• Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes (2024 · Gastroenterology · 被引 129)
• Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study (2024 · Molecular Psychiatry · 被引 83)